Maryam Tehranipour | Pharmacology | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Maryam Tehranipour | Pharmacology | Best Researcher Award

Animal Physiology | Islamic Azad University | Iran

Dr. Maryam Tehranipour is an accomplished Associate Professor in the Department of Biology at the Islamic Azad University, Mashhad, Iran, recognized for her distinguished contributions to the fields of diabetes, metabolic disorders, neurobiology, oxidative stress, and cancer biology. Holding a Ph.D. in Animal Physiology, she has built a dynamic academic and research career integrating cellular physiology, pharmacology, and molecular mechanisms of disease. Her extensive publication record spans a broad spectrum of biomedical investigations, including neuroprotective strategies, natural product pharmacology, nanomedicine, and experimental models of diabetes and neurodegeneration. Dr. Tehranipour’s pioneering studies have elucidated the roles of oxidative damage, angiogenesis, and neuronal regeneration in disease progression and therapeutic recovery, particularly highlighting the potential of bioactive compounds and nanocarrier systems in drug design and targeted therapy. Her collaborative work has advanced understanding of diabetic complications, nerve injury repair, and cancer cell modulation through natural and synthetic agents. Beyond her prolific research output, she has played a significant role in mentoring undergraduate, graduate, and doctoral students, fostering scientific rigor and innovation in physiological research. Her scholarly influence is reflected through her indexed publications, contributions to interdisciplinary research networks, and global collaborations that link physiology, biochemistry, and nanotechnology for translational health impact. Dr. Tehranipour’s scientific endeavors emphasize the integration of experimental biology with clinical relevance, aiming to bridge laboratory discoveries with therapeutic applications. Through her ongoing research, she continues to contribute meaningfully to global biomedical science, particularly in developing sustainable and biologically safe therapeutic interventions addressing chronic and degenerative diseases that pose major public health challenges. She has 238 citations from 53 documents with an h-index of 9.

Profile: Scopus 

Featured Publications

1. The Umbelliprenin-CTAB cellulose nanocrystal delivery system prevents hyperglycemia in diabetic rats by activating the insulin receptor IR/PDK1 pathway. (2025). Scientific Reports. Open access.

2. The effects of N-butanol and ethyl acetate fractions of Ferula asafoetida hydroalcoholic extract on the expression of VEGF and FGF genes in the chorioallantoic membrane of chick embryos. (2025). Journal of Veterinary Research.Open access.

3. Bimetallic-based colorimetric aptasensor for the quantitative analysis of ampicillin using catalytic activity of ZrFe metal–organic framework and terminal deoxynucleotidyl transferase-assisted signal amplification. (2025). Bionanoscience. Open access.

4. The effect of Ziziphora clinopodioides hydroalcoholic extract on the neuronal density and histopathology of the hippocampal area CA2 in streptozotocin-induced Alzheimer’s model in male rats. (2025). Journal of Chemical Health Risks. Open access.

5. A novel alpha-terpineol-loaded niosome formulation coated with hyaluronic acid and evaluation of its anticancer properties in vitro. (2025). Journal of Molecular Liquids. Open access.

Reham Abdelkader | Pharmacology | Best Researcher Award

Published on by Health Scientists

Prof. Reham Abdelkader | Pharmacology | Best Researcher Award 

Head of department | German university in Cairo | Egypt

Dr. Reham Mahmoud Abdel-Kader, Professor of Pharmacology and Toxicology and Chair of the Department at the German University in Cairo, is a distinguished biomedical scientist whose research bridges molecular pharmacology, neurodegenerative diseases, and cancer biology with translational therapeutic innovation. Her scientific contributions focus on elucidating mitochondrial dysfunction, neuroinflammation, and cellular bioenergetics as critical mechanisms in Alzheimer’s disease and oncological disorders, advancing targeted treatment approaches through nanotechnology and pharmacogenomic insights. Dr. Abdel-Kader has established two active research groups investigating Alzheimer’s pathology and mitochondrial roles in breast cancer progression, fostering a strong translational link between bench discovery and therapeutic development. She has published widely in internationally recognized journals in pharmacology, neurobiology, and molecular medicine, and her work has received global recognition through prestigious conference presentations and features in leading scientific outlets. Her research has attracted significant international funding from agencies such as the Swiss National Science Foundation, DAAD-BMBF, and the Science and Technology Development Fund, reflecting the impact and sustainability of her scientific endeavors. A committed academic leader, she has played a vital role in curriculum development, accreditation processes, and capacity-building initiatives that enhance educational quality and research excellence within her institution. Dr. Abdel-Kader actively collaborates with leading scientists and institutions across Europe, including partnerships in Germany and Switzerland, fostering international scientific exchange and innovation. Her patent in nanocomposite synthesis further underscores her commitment to bridging pharmaceutical research and technology-based solutions. Through her scholarly rigor, mentorship, and collaborative leadership, Dr. Abdel-Kader continues to contribute significantly to global pharmacological sciences and to shaping the next generation of health researchers dedicated to advancing human health and societal well-being.

Profiles: Google Scholar | ORCID

Featured Publications

1. Leuner, K., Hauptmann, S., Abdel-Kader, R., Scherping, I., Keil, U., & others. (2007). Mitochondrial dysfunction: The first domino in brain aging and Alzheimer’s disease? Antioxidants & Redox Signaling,

2. Abdel-Kader, R., Hauptmann, S., Keil, U., Scherping, I., Leuner, K., Eckert, A., & others. (2007). Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761). Pharmacological Research,

3. Eckert, G. P., Renner, K., Eckert, S. H., Eckmann, J., Hagl, S., Abdel-Kader, R. M., & others. (2012). Mitochondrial dysfunction—A pharmacological target in Alzheimer’s disease. Molecular Neurobiology,

4. Franke, C., Nöldner, M., Abdel-Kader, R., Johnson-Anuna, L. N., Wood, W. G., & others. (2007). Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment. Neurobiology of Disease

5. Eckert, G. P., Schiborr, C., Hagl, S., Abdel-Kader, R., Müller, W. E., & Rimbach, G. (2013). Curcumin prevents mitochondrial dysfunction in the brain of the senescence-accelerated mouse-prone 8. Neurochemistry International.

Sina Andalib | Pharmacology | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Sina Andalib | Pharmacology | Best Researcher Award

correspond author | Zanjan university of medical sciences | Iran

Dr. Sina Andalib is an Associate Professor at the Department of Pharmacology, Pharmacy Faculty, Zanjan University of Medical Sciences, Iran. He earned his Doctor of Veterinary Medicine (DVM) from Tabriz Azad University in 2005, focusing on anti-inflammatory effects of statins, and completed his PhD at Tabriz University of Medical Sciences in 2013, investigating the cardioprotective effects of Atorvastatin in isoproterenol-induced heart failure in rats. Dr. Andalib’s research spans pharmacology, neurodegenerative diseases, drug delivery systems, and natural product therapeutics, with a particular focus on Alzheimer’s disease, Parkinson’s disease, diabetes, and cancer. He has supervised numerous PhD and PharmD theses exploring innovative nanoparticle-based drug delivery, herbal and synthetic compound interventions, and molecular mechanisms underlying neuroprotection and cardioprotection. His work has been published extensively in high-impact international journals including ACS Chemical Neuroscience, Journal of Pharmaceutical Sciences, International Journal of Pharmaceutics, and European Journal of Pharmacology, covering topics such as nanocomposite hydrogels for wound healing, fullerene-based interventions in Alzheimer’s models, and polypharmacological effects of anticancer compounds. Dr. Andalib has contributed to several internationally collaborative projects, including the development of nanocomposites for neuroprotection and polypharmacological studies of anticancer compounds in organoid models. He has received recognition for his scientific contributions in pharmacology and neurotherapeutics and serves on editorial boards of peer-reviewed journals in pharmacology and drug delivery research. In addition to his research, he holds leadership roles at Zanjan University, including Head of the Department of Pharmacology and Toxicology and Head of the Education Development Office, fostering academic development and innovative research in pharmaceutical sciences. He has 751 citations from 39 documents with an h-index of 15.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Danafar, H., Sharafi, A., Kheiri Manjili, H., & Andalib, S. (2017). Sulforaphane delivery using mPEG–PCL co-polymer nanoparticles to breast cancer cells.

2. Garjani, A., Fathiazad, F., Zakheri, A., Akbari, N. A., Azarmie, Y., Fakhrjoo, A., et al. (2009). The effect of total extract of Securigera securidaca L. seeds on serum lipid profiles, antioxidant status, and vascular function in hypercholesterolemic rats.

3. Barzegar-Jalali, M., Alaei-Beirami, M., Javadzadeh, Y., Mohammadi, G., et al. (2012). Comparison of physicochemical characteristics and drug release of diclofenac sodium–eudragit® RS100 nanoparticles and solid dispersions.

4. Garjani, A., Andalib, S., Biabani, S., Soraya, H., Doustar, Y., & Garjani, A., et al. (2011). Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat.

5. Abedimanesh, N., Asghari, S., Mohammadnejad, K., Daneshvar, Z., et al. (2021). The anti-diabetic effects of betanin in streptozotocin-induced diabetic rats through modulating AMPK/SIRT1/NF-κB signaling pathway.

Amin Hasanvand | Pharmacology | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Amin Hasanvand | Pharmacology | Best Researcher Award

Associate Professor | Lorestan University | Iran

Dr. Amin Hasanvand, Associate Professor in the Department of Pharmacology at Lorestan University of Medical Sciences, is an accomplished Iranian pharmacologist and biomedical scientist whose career reflects excellence in research, teaching, and leadership in health sciences. He earned his Ph.D. in pharmacology from Tehran University of Medical Sciences in 2016, with a doctoral thesis focused on the AMPK signaling pathway and its role in diabetic neuropathy, and has since developed a robust academic profile. His research interests span pharmacology, diabetes, nephropharmacology, inflammation, neuropathy, and neuroscience, with particular focus on AMPK-dependent mechanisms, metformin, gut microbiome modulation, and novel strategies for neuropathic pain management. Over the years, Dr. Hasanvand has published more than 50 peer-reviewed articles in SCI and Scopus-indexed journals, authored two academic books titled Medical Pharmacology Education and Antibiotics: Mechanisms of Action and Clinical Applications, and contributed to over 40 completed research projects, while actively mentoring medical and pharmacy students. He also serves as Editor of the Herbal Medicine Journal and as an editorial board member of Annals of Pharmacology and Immunopathologia Persa, alongside being a reviewer for leading international journals such as Journal of Neuroimmune Pharmacology, Cancer Control, and Obesity Reviews. In recognition of his impactful contributions, Dr. Hasanvand has been honored seven times as the top researcher at his university and was ranked among the world’s top 2% most influential scientists in 2023. His distinguished career reflects an enduring commitment to advancing pharmacological sciences and improving health outcomes through research, innovation, and education. He has 809 citations from 38 documents with an h-index of 14.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Mir, S., Abbaszadeh, A., Hasanpour Dehkordi, A., & Hasanvand, A. (2019). Metformin and its anti-inflammatory and anti-oxidative effects; new concepts. Journal of Renal Injury Prevention.

2. Hasanvand, A., Kharazmkia, A., Mir, S., Khorramabadi, R. M., & Darabi, S. (2018). Ameliorative effect of ferulic acid on gentamicin-induced nephrotoxicity in a rat model; role of antioxidant effects. Journal of Renal Injury Prevention.

3. Khorramabadi, R. M., Amanolahi Baharvand, P., Pirzadroozbahani, N., Hasanvand, A., Kharazmkia, A., Goudarzi, M., Mir, S., & Ahmadizar, F. (2018). Evaluation of the antioxidant effects of zolpidem in the rat model of cisplatin-induced nephrotoxicity. Journal of Renal Injury Prevention.

4. Hasanvand, A., Amini-Khoei, H., Jahanabadi, S., Hadian, M.-R., Abdollahi, A., Tavangar, S. M., Mehr, S. E., & Dehpour, A. R. (2018). Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through activation of AMPK signaling pathway. Journal of Nephropathology.

5. Abbaszadeh, A., Koushki, S., Koushki, S., Eskandarzadeh, M., & Hasanvand, A. (2018). Metformin; a mini-review to its antioxidative and anti-inflammatory properties. Journal of Renal Injury Prevention.

6. Babaeenezhad, E., & Hasanvand, A. (2018). Renoprotective impacts of metformin with insulin in type 1 diabetes; role of its antioxidant efficacy. Journal of Nephropathology.

Paramanna Poojari | Pharmacology | Best Researcher Award

Published on by Health Scientists

Mr. Paramanna Poojari | Pharmacology | Best Researcher Award

Research Scholar | Karnatak University Dharwad | India

Dr. Paramanna Poojari, currently serving as a Research Scholar in the Department of Biochemistry at Karnatak University Dharwad, has built a strong academic and professional foundation in the fields of biochemistry, microbiology, nanotechnology, and cell culture. He holds a postgraduate degree in biochemistry and has specialized in experimental and applied research with a focus on nanoscience, cancer biology, drug delivery systems, and phytoremediation. Dr. Poojari’s research explores the potential of nanoparticles, plant tissue culture, antibiotic sensitivity testing, and nanomaterial characterization, with the objective of advancing innovative solutions for healthcare, pharmaceuticals, and environmental sustainability. His scholarly contributions include publications in highly regarded international journals indexed in Scopus, Google Scholar, and UGC CARE list, such as Drug Delivery Science and Technology, Water Air and Soil Pollution, and Dispersion Science and Technology, with a citation index of 24 and an h-index of 3. He has also contributed a book chapter published with ISBN: 9781032699882, further strengthening his academic profile. In recognition of his growing expertise, Dr. Poojari has been entrusted with editorial and peer-review responsibilities for reputed publishers including Elsevier and Springer Nature, underscoring his role in maintaining research quality and scientific integrity. His collaborations with nanotechnology laboratories have enabled interdisciplinary exploration bridging life sciences and material sciences. With patents under preparation and continued innovation in biotechnology applications, Dr. Poojari exemplifies a dedicated young scientist committed to impactful research. His academic achievements and professional contributions highlight his potential as a future leader in health sciences and allied fields. He has 18 citations from 8 documents with an h-index of 3.

Profile: Google Scholar | Scopus | ORCID

Publications

1. Ganeshkar, M. P., Gaddigal, A. T., Shivappa, P., Poojari, P. B., Goder, P. H., … (2023). Biocompatibility assessment of Rutin and PEG loaded novel nanoceria on human erythrocytes and human myeloid leukemia (U937) cells. Journal of Drug Delivery Science and Technology, 86, 104761.

2. Gaddigal, A. T., Shivappa, P., Ganeshkar, M. P., Mirjankar, M. R., Poojari, P. B., … (2024). Green synthesis of copper oxide nanoparticles using Simarouba glauca leaf extract, characterization and screening for their biological applications. Journal of Dispersion Science and Technology, 1–15.

3. Mirjankar, M. R., Pattar, S. V., Gaddigal, A. T., Shivappa, P., Poojari, P. B., … (2023). Phytoremediation of copper contaminated water using Pistia stratiotes and emphasis of thermal stability in response to metal stress. Water Conservation Science and Engineering, 8(1), 24.

4. Mirjankar, M. R., Pattar, S. V., Gaddigal, A. T., Shivappa, P., Poojari, P. B., … (2023). Isolation of culturable endophytic bacteria from the roots of Aloe vera L. (Aloe barbadensis Miller) and their application in phytodegradation of xenobiotics. Water, Air, & Soil Pollution, 234(7), 451.

5. Shivappa, P., Mirjankar, M. R., Gaddigal, A. T., Ganeshkar, M. P., Poojari, P. B., … (2023). Bismuth nanoparticle synthesis utilizing hydroalcoholic Endocomia macrocoma leaf extract to evaluate their antimicrobial, antioxidant, and anticancer properties. Journal of Dispersion Science and Technology, 1–15.